Upper Cross Syndrome and Neck Proprioception

January 29, 2025 updated by: Omnia Mohamed Said El-Sayed, Cairo University

Correlation Between Upper Cross Syndrome and Neck Proprioception

Correlation Between Upper Cross Syndrome and Neck Proprioception

Hypothesis:

No statistically significant relationship exists between upper cross syndrome and neck proprioception.

Study Design:

Randomized Controlled Trial

Participants:

Office workers (≥4h computer use/day) Age: 28-48 years Chronic nonspecific neck pain (>3 months) Forward head posture (FHP) <46° VAS score: 3-8 cm No cognitive impairments affecting participation

Exclusion Criteria:

Systemic, rheumatic, or neuromuscular diseases Neurological signs, spinal surgery, or recent physical therapy Missing ≥3 consecutive or 4 nonconsecutive sessions

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Study Title:Correlation Between Upper Cross Syndrome and Neck Proprioception

Hypothesis:There will be no statistically significant relationship between upper cross syndrome and neck proprioception.

Methodology:

Study Design:Randomized controlled trial

Inclusion Criteria:

Office workers using a computer for at least 4 hours daily

Aged between 28 and 48 years

Neck pain (NP) between 3 and 8 cm on a visual analog scale (VAS) (0 = no pain, 10 = unbearable pain)

Chronic nonspecific neck pain lasting for more than 3 months

Forward head posture (FHP) less than 46°

Patients willing and able to participate in an exercise program safely without cognitive impairments that would limit participation

Exclusion Criteria:

Specific causes of NP (e.g., systemic, rheumatic, neuromuscular diseases)

Central or peripheral neurological signs

Cognitive impairment

History of spinal surgery

Physical therapy treatments in the last 6 months prior to baseline assessment

Participants missing at least three consecutive or four nonconsecutive sessions

Outcome Measures:

Spinal Curvature Assessment Using Spinal Mouse DeviceThe spinal mouse device is physically guided along the skin of the spine

Neck Pain MeasurementNP is evaluated using a 10-cm VAS, a widely used clinical tool for assessing pain treatment effectiveness.

Neck Disability Index (NDI)Disability is assessed using the NDI questionnaire.

Measurement of Cervical Range of Motion (CROM) Using a CROM

Assessment of Cervical Proprioception Using the CROM DeviceHead Reposition Accuracy Tests:

Neutral Head Position (NHP) Test: Measures the ability to actively reposition the head to the self-selected neutral position.

Target Head Position (THP) Test: Measures the ability to actively reposition the head to a previously demonstrated target position.

Study Type

Observational

Enrollment (Estimated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The study population consists of adult office workers with specific characteristics related to their occupation, posture, and neck pain history. Below is a detailed breakdown:

Demographic Characteristics

Age Range: 28-48 years. Gender: Not specified, but likely includes both males and females. Occupation: Office workers using computers for at least 4 hours daily.

Clinical Characteristics

Chronic Nonspecific Neck Pain (CNP):

Pain lasting ≥3 months. Pain intensity between 3-8 cm on the Visual Analog Scale (VAS).

Forward Head Posture (FHP):

Measured angle of FHP is less than 46°.

No Specific Diagnoses:

Participants with neck pain due to systemic, rheumatic, or neuromuscular diseases are excluded.

Description

Inclusion Criteria:

  • office workers (using a computer at least 4 h),

    • aged between 28 and 48 years,
    • NP between 3 and 8 cm on a visual analog scale (VAS) (from 0 indicating no pain at all to 10 indicating unbearable pain),
    • chronic nonspecific neck pain lasting for more than 3 months, and FHP less than 46° (Fathollahnejad et al., 2019).
    • Patients willing and able to participate in an exercise program safely and without cognitive impairments that would limit their participation.

Exclusion Criteria:

  • specific causes of NP (e.g., systemic, rheumatic, neuromuscular diseases), central or peripheral neurological signs, cognitive impairment, spinal surgery, or physical therapy treatments in the last 6 months prior to the baseline assessment.
  • Participants would be also excluded if they missed at least three consecutive or four nonconsecutive sessions (Fathollahnejad et al., 2019).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
control group
Participants with UCS who do not receive the intervention (e.g., may receive standard care, education, or no treatment).
Group/Cohort Description: Participants with Upper Cross Syndrome (UCS) who undergo the prescribed exercise or treatment protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cervical Proprioception:
Time Frame: 8 weeks

Measurement Tool: CROM device.

Tests:

Neutral Head Position (NHP): Assesses participants' ability to actively reposition their head to a self-selected neutral position.

Target Head Position (THP): Assesses ability to reposition the head to a previously demonstrated target position.

8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance
Time Frame: 8 weeks

Measurement Tool: Biodex Balance System.

Parameters:

Static and dynamic balance. Postural stability score (lower scores indicate better balance). Purpose: Explore the effect of UCS on overall balance and stability.

8 weeks
Neck Disability Index (NDI):
Time Frame: 8 weeks
Measurement Tool: NDI questionnaire. Purpose: Assess the impact of neck pain on daily activities and functional limitations.
8 weeks
Cervical Range of Motion (CROM)
Time Frame: 8 weeks
Measurement Tool: CROM device. Purpose: Measure the range of motion in the cervical spine to detect restrictions due to UCS.
8 weeks
Neck Pain
Time Frame: 8 weeks

Measurement Tool: Visual Analog Scale (10-cm scale)

Purpose: Evaluate participants' subjective pain levels before and after the intervention.

Scale Range: 0 (no pain) to 10 (unbearable pain). Interpretation: Higher scores indicate worse pain levels.

8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spinal Curvature:
Time Frame: 8 weeks

Measurement Tool: Spinal Mouse Device.

Parameters:

Sagittal plane alignment in neutral, flexion, and extension.

Purpose: Assess structural changes or adaptations in the spine due to UCS.

8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2025

Primary Completion (Estimated)

July 25, 2025

Study Completion (Estimated)

October 25, 2025

Study Registration Dates

First Submitted

January 25, 2025

First Submitted That Met QC Criteria

January 25, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 29, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/005030

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Upper Cross Syndrome

Clinical Trials on Intervention Group

Subscribe